LEIDOS BIOMEDICAL RESEARCH, INC.
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NES-100 AS A NASAL SPRAY OF A NEW ANALGESIC
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NES-100 AS A NASAL SPRAY OF A NEW ANALGESIC is a funding opportunity from LEIDOS BIOMEDICAL RESEARCH, INC., up to 1346384, closing September 14, 2030.
Sep 14, 2030
(1506d left)Overview
This is to award the contract to perform all the tasks listed here. Offeror is referred to contractor/subcontractor hereafter. NES100 is formulated by high pressure homogenization of MET and LENK to form nanoparticles, followed by spray drying to produce MET-LENK microparticles. The microparticle powder is then filled…